JP2016507723A - 結腸腫瘍の存在またはリスクの評価方法 - Google Patents

結腸腫瘍の存在またはリスクの評価方法 Download PDF

Info

Publication number
JP2016507723A
JP2016507723A JP2015545504A JP2015545504A JP2016507723A JP 2016507723 A JP2016507723 A JP 2016507723A JP 2015545504 A JP2015545504 A JP 2015545504A JP 2015545504 A JP2015545504 A JP 2015545504A JP 2016507723 A JP2016507723 A JP 2016507723A
Authority
JP
Japan
Prior art keywords
proteins
subject
analysis
amount
pkm2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015545504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016507723A5 (cg-RX-API-DMAC7.html
Inventor
ブルーム，ジョン
ベンツ，ライアン
クロナー，リサ
ディ
ディロン，ロズリン
ランドール，アルロ
ジョーンズ，ジェフリー
スコア，ヘザー
ストックフィッシュ，トム
ウィルコックス，ブルース
ルダーマン，ダニエル
Original Assignee
アプライド・プロテオミクス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アプライド・プロテオミクス，インコーポレイテッド filed Critical アプライド・プロテオミクス，インコーポレイテッド
Publication of JP2016507723A publication Critical patent/JP2016507723A/ja
Publication of JP2016507723A5 publication Critical patent/JP2016507723A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Bioethics (AREA)
JP2015545504A 2012-11-30 2013-12-02 結腸腫瘍の存在またはリスクの評価方法 Pending JP2016507723A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261732024P 2012-11-30 2012-11-30
US61/732,024 2012-11-30
US201361772979P 2013-03-05 2013-03-05
US61/772,979 2013-03-05
PCT/US2013/072691 WO2014085826A2 (en) 2012-11-30 2013-12-02 Method for evaluation of presence of or risk of colon tumors

Publications (2)

Publication Number Publication Date
JP2016507723A true JP2016507723A (ja) 2016-03-10
JP2016507723A5 JP2016507723A5 (cg-RX-API-DMAC7.html) 2017-01-19

Family

ID=50828610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015545504A Pending JP2016507723A (ja) 2012-11-30 2013-12-02 結腸腫瘍の存在またはリスクの評価方法

Country Status (11)

Country Link
US (6) US20140234854A1 (cg-RX-API-DMAC7.html)
EP (1) EP2926138A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016507723A (cg-RX-API-DMAC7.html)
KR (1) KR20150090240A (cg-RX-API-DMAC7.html)
CN (2) CN104969071B (cg-RX-API-DMAC7.html)
AU (1) AU2013351947A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015012616A2 (cg-RX-API-DMAC7.html)
CA (1) CA2893158A1 (cg-RX-API-DMAC7.html)
MX (1) MX2015006757A (cg-RX-API-DMAC7.html)
SG (1) SG11201504241QA (cg-RX-API-DMAC7.html)
WO (1) WO2014085826A2 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017198509A (ja) * 2016-04-26 2017-11-02 学校法人近畿大学 大腸癌マーカー
JP2020500293A (ja) * 2016-10-07 2020-01-09 ディサーンディーエックス，インク． 大腸癌及び進行性腺腫を検知するためのタンパク質バイオマーカーパネル
JP2022531058A (ja) * 2019-03-06 2022-07-06 ディアデム エス．アール．エル． アルツハイマー病の診断と予後判定におけるマーカーとしてのｐ５３ペプチド

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
CA2863819C (en) 2012-02-09 2021-11-23 Memed Diagnostics Ltd. Signatures and determinants for diagnosing infections and methods of use thereof
CA2943827A1 (en) * 2014-03-28 2015-10-01 Applied Proteomics, Inc. Protein biomarker profiles for detecting colorectal tumors
EP3167293B1 (en) * 2014-07-11 2020-03-18 Expression Pathology, Inc. Srm/mrm assay for the gtpase kras protein (kras)
EP3699930B1 (en) 2014-08-14 2024-02-07 MeMed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
WO2016037134A1 (en) * 2014-09-05 2016-03-10 Nantomics, Llc Systems and methods for determination of provenance
JP2017538938A (ja) * 2014-12-11 2017-12-28 ウイスコンシン・アルムニ・リサーチ・ファンデーション 大腸癌の検出及び処置方法
CN107209184B (zh) 2014-12-11 2020-04-24 米密德诊断学有限公司 用于诊断多种感染的标记组合及其使用方法
CN105807062A (zh) * 2014-12-28 2016-07-27 复旦大学 人结肠癌蛋白Spondin-2在制备结肠癌诊断制剂中的应用
CN105385752A (zh) * 2015-03-23 2016-03-09 复旦大学 一种人结肠癌蛋白质标志物Spondin-2的检测方法及其检测试剂盒
CA2982169A1 (en) 2015-04-10 2016-10-13 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
EP3316875B1 (en) * 2015-07-01 2021-11-17 Duke University Methods to diagnose acute respiratory infections
WO2017078787A1 (en) * 2015-11-05 2017-05-11 Vanderbilt University Protein quantitation in multicellular tissue specimens
WO2017149548A1 (en) 2016-03-03 2017-09-08 Memed Diagnostics Ltd. Rna determinants for distinguishing between bacterial and viral infections
EP3443497A1 (en) * 2016-04-11 2019-02-20 DiscernDx, Inc. Mass spectrometric data analysis workflow
CN107345236A (zh) * 2016-05-04 2017-11-14 北京美泽福临科技发展有限公司 一种amy2b信使rna的特异性扩增引物和肝癌辅助诊断试剂盒
CA3025004A1 (en) * 2016-06-10 2017-12-14 Wisconsin Alumni Research Foundation Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas
EP4141448A1 (en) 2016-07-10 2023-03-01 MeMed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018011796A1 (en) 2016-07-10 2018-01-18 Memed Diagnostics Ltd. Early diagnosis of infections
CN106202984B (zh) * 2016-08-26 2018-09-04 赵毅 一种基于多层复杂网络对肿瘤miRNA标志物的筛选方法
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
EP3519834A4 (en) * 2016-09-29 2020-06-17 MeMed Diagnostics Ltd. RISK ASSESSMENT AND DISEASE CLASSIFICATION METHODS
CN110214271B (zh) * 2017-01-19 2022-11-15 株式会社岛津制作所 分析数据解析方法以及分析数据解析装置
US11204355B2 (en) 2017-02-20 2021-12-21 Vanderbilt University Immune checkpoint molecular fitness profiling by mass spectrometry
CN106919801B (zh) * 2017-03-08 2023-07-18 杭州大伽信息科技有限公司 一种免疫组织化学染色辅助分析系统及使用方法
CN106908608B (zh) * 2017-04-17 2018-10-02 首都医科大学附属北京胸科医院 辅助诊断重症继发性肺结核的蛋白标志物
US20180330059A1 (en) * 2017-05-09 2018-11-15 James Stewart Bates Patient treatment systems and methods
US10455457B2 (en) 2017-05-24 2019-10-22 Qualcomm Incorporated NR-SS unified operation mode in coordinated and uncoordinated bands
US11164679B2 (en) 2017-06-20 2021-11-02 Advinow, Inc. Systems and methods for intelligent patient interface exam station
US20200124604A1 (en) * 2017-06-30 2020-04-23 National Institutes Of Biomedical Innovation, Health And Nutrition Biomarker for detecting colorectal cancer
CN111164700B (zh) * 2017-07-14 2024-10-29 余因子基因组学公司 使用下一代测序的免疫-肿瘤学应用
CN109406785A (zh) * 2017-08-18 2019-03-01 山东泽济生物科技有限公司 肿瘤血液标志物及其应用
EP3721232A1 (en) * 2017-12-05 2020-10-14 DiscernDx, Inc. Robust panels of colorectal cancer biomarkers
EP3732489B1 (en) * 2017-12-29 2025-10-22 Abbott Laboratories Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
ES2917629T3 (es) * 2018-01-22 2022-07-11 Liquid Biopsy Res Llc Métodos para la detección del cáncer de colon y monitorización del tratamiento
US11348688B2 (en) 2018-03-06 2022-05-31 Advinow, Inc. Systems and methods for audio medical instrument patient measurements
EP3776381A4 (en) 2018-04-13 2022-01-05 Freenome Holdings, Inc. IMPLEMENTATION OF MACHINE LEARNING FOR MULTI-ANALYTE TESTS OF BIOLOGICAL SAMPLES
EP3818376A1 (en) * 2018-07-05 2021-05-12 EDP Biotech Corporation Kits and methods for detecting markers
EA202190355A1 (ru) 2018-08-08 2021-05-25 Ридженерон Фармасьютикалз, Инк. Применение жх-мс/мс для количественного определения белковых биомаркеров
EP3623813A1 (en) * 2018-09-17 2020-03-18 Institut d'Investigació Sanitària Pere Virgili Methods for the prognosis of hiv-infected subjects
WO2021097302A1 (en) * 2019-11-13 2021-05-20 University Of South Florida Systems and methods of deep learning for colorectal polyp screening
CN110951707B (zh) * 2019-12-31 2022-11-11 南京医科大学 丙酮酸激酶m2突变体及其在心血管疾病中的应用
CN115616230A (zh) * 2020-03-18 2023-01-17 龙海市第一医院 用于肝癌早期诊断的检测岩藻糖基化载脂蛋白h的elisa试剂盒
WO2022006628A1 (en) * 2020-07-08 2022-01-13 Southern Adelaide Local Health Network Inc. Computer-implemented method and system for identifying measurable features for use in a predictive model
CN112194719A (zh) * 2020-09-01 2021-01-08 中日友好医院(中日友好临床医学研究所) Crt抗原和mage-a1抗原的制备及其应用
CN112034182A (zh) * 2020-09-01 2020-12-04 复旦大学附属中山医院 一种结肠癌转移预测方法和系统
CN112266961B (zh) * 2020-10-29 2023-05-12 中山大学附属第六医院 Tsg-6基因在预测结直肠癌转移及预后方面的应用
CN112710856B (zh) * 2020-12-16 2022-12-02 江西省肿瘤医院(江西省癌症中心) 检测血清igf1蛋白的制剂在制备结直肠癌疗效监测试剂中的应用
CN113447658B (zh) * 2021-07-01 2022-04-19 浙江大学 一种检测抗过氧化物还原酶-1-IgG抗体的试剂盒
CN113956327B (zh) * 2021-10-11 2024-01-30 中山大学肿瘤防治中心 靶向人apc蛋白的多肽及其在制备药物中的应用
EP4497005A1 (en) * 2022-03-23 2025-01-29 Serum Detect, Inc. Biomarker signatures indicative of early stages of cancer
CN114445406B (zh) * 2022-04-07 2022-08-09 武汉大学 肠镜图像分析方法、装置和医学图像处理设备
TWI796228B (zh) 2022-05-25 2023-03-11 臺中榮民總醫院 急性腎損傷預測系統及其方法
CN114668836B (zh) * 2022-05-27 2022-08-19 暨南大学 Pdia6在制备治疗脊髓损伤和修复的药物中的应用
CN114958794B (zh) * 2022-06-14 2023-06-02 南京工业大学 一种苯乙醇胺-N-甲基转移酶hPNMT54及其克隆表达与应用
CN116593431B (zh) * 2023-04-09 2025-11-07 湖南科技大学三亚研究院 一种基于亲和传感器法的米酵菌酸毒素便携式检测装置及检测方法
WO2024232926A1 (en) * 2023-05-08 2024-11-14 Venn Biosciences Corporation Diagnosis of colorectal cancer using targeted quantification of peptides
WO2025058445A1 (ko) * 2023-09-15 2025-03-20 연세대학교 산학협력단 대장암에 대한 정보 제공 방법
CN118067993B (zh) * 2024-04-17 2024-07-05 弗雷米德生物医药技术（天津）有限公司 一种用于肠息肉检测的联检试剂盒及其制备方法、检测方法和应用
CN118496322A (zh) * 2024-05-09 2024-08-16 昆明医科大学 一种靶向降解β-catenin的多肽型抑制剂及其应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003065003A2 (en) * 2002-01-25 2003-08-07 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
WO2006053592A1 (en) * 2004-08-13 2006-05-26 Indivumed Gmbh Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same
US20080145852A1 (en) * 2005-03-01 2008-06-19 Shuber Anthony P Methods and compositions for detecting adenoma
JP2010533853A (ja) * 2007-07-19 2010-10-28 ビオメリュー 結腸直腸癌のインビトロ診断のための肝臓脂肪酸結合タンパク質、ｃｅａおよびｃａ１９−９のアッセイのための方法
US20100304410A1 (en) * 2007-09-28 2010-12-02 Royal College Of Surgeons In Ireland Method of assessing colorectal cancer status in an individual
JP2010281836A (ja) * 2004-02-19 2010-12-16 Yale Univ プロテオーム技術を使用した癌タンパク質バイオマーカーの同定
JP2011506917A (ja) * 2007-12-10 2011-03-03 エフ．ホフマン−ラ ロシュ アーゲー 結腸直腸癌のためのマーカーパネル

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4517289A (en) * 1982-08-18 1985-05-14 Brigham And Women's Hospital Monoclonal antibodies for human tissue cross-matching
JP2002515965A (ja) * 1995-08-18 2002-05-28 ダブリュー． ランドリ，ドナルド 抗体触媒反応の調節による有機化合物の検出
US5800347A (en) * 1995-11-03 1998-09-01 The General Hospital Corporation ROC method for early detection of disease
NO954667D0 (no) * 1995-11-17 1995-11-17 Dagfinn Oegreid Fremgangsmåte til deteksjon av Ki-ras mutasjoner
EP1179092A2 (en) * 1999-01-10 2002-02-13 Exact Sciences Corporation Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
US20010041365A1 (en) * 2000-01-10 2001-11-15 Michael Laposata Methods for monitoring alcohol consumption
US20050153382A1 (en) * 2002-06-06 2005-07-14 Chengdu Kuachang Science And Technology Co., Ltd. Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
US20060105419A1 (en) * 2004-08-16 2006-05-18 Biosite, Inc. Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
CN101283280A (zh) * 2005-08-18 2008-10-08 Zadec私人有限公司 用于诊断结直肠癌的蛋白质标记和所述标记作为所述癌症类型治疗的药物靶点的用途
EP2177910A1 (en) * 2005-11-10 2010-04-21 Aurelium Biopharma Inc. Tissue diagnostics for breast cancer
CA2706115A1 (en) * 2007-12-10 2009-06-18 F. Hoffmann-La Roche Ag Seprase as a marker for cancer
AU2009213671A1 (en) * 2008-02-11 2009-08-20 Hadasit Medical Research Services & Development Limited Colon cancer associated transcript 1 (CCAT1) as a cancer marker
US20110076700A1 (en) * 2008-02-29 2011-03-31 Nihon University Anti-crp antibody and utilization of the same
EP2255017A1 (en) * 2008-03-18 2010-12-01 Epigenomics AG A method for optimizing and validating an assay for determining the presence or absence of a medical condition
CA2724433A1 (en) * 2008-05-14 2009-11-19 Eth Zuerich Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
EP2796878A1 (en) * 2008-05-23 2014-10-29 Biocartis NV New biomarkers for diagnosis, prediction and/or prognosis of sepsis and uses thereof
AU2010306593B2 (en) * 2009-10-15 2015-09-10 Crescendo Bioscience, Inc. Biomarkers and methods for measuring and monitoring inflammatory disease activity
US10119959B2 (en) * 2010-06-25 2018-11-06 The Board Of Trustees Of The Leland Stanford Junior University Method of assaying an individual for immune impairment
EP2668503B1 (en) * 2011-01-28 2015-06-24 F.Hoffmann-La Roche Ag Combinatorial biomarkers for clinical applications in lung cancer patient management
WO2012115885A1 (en) * 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
CA2845568A1 (en) * 2011-08-19 2013-02-28 Myriad Genetics, Inc. Gene signatures for lung cancer prognosis and therapy selection

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003065003A2 (en) * 2002-01-25 2003-08-07 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
JP2010281836A (ja) * 2004-02-19 2010-12-16 Yale Univ プロテオーム技術を使用した癌タンパク質バイオマーカーの同定
WO2006053592A1 (en) * 2004-08-13 2006-05-26 Indivumed Gmbh Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same
US20080145852A1 (en) * 2005-03-01 2008-06-19 Shuber Anthony P Methods and compositions for detecting adenoma
JP2010533853A (ja) * 2007-07-19 2010-10-28 ビオメリュー 結腸直腸癌のインビトロ診断のための肝臓脂肪酸結合タンパク質、ｃｅａおよびｃａ１９−９のアッセイのための方法
US20100304410A1 (en) * 2007-09-28 2010-12-02 Royal College Of Surgeons In Ireland Method of assessing colorectal cancer status in an individual
JP2011506917A (ja) * 2007-12-10 2011-03-03 エフ．ホフマン−ラ ロシュ アーゲー 結腸直腸癌のためのマーカーパネル

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017198509A (ja) * 2016-04-26 2017-11-02 学校法人近畿大学 大腸癌マーカー
JP2020500293A (ja) * 2016-10-07 2020-01-09 ディサーンディーエックス，インク． 大腸癌及び進行性腺腫を検知するためのタンパク質バイオマーカーパネル
JP2022531058A (ja) * 2019-03-06 2022-07-06 ディアデム エス．アール．エル． アルツハイマー病の診断と予後判定におけるマーカーとしてのｐ５３ペプチド
JP7539399B2 (ja) 2019-03-06 2024-08-23 ディアデム エス．アール．エル． アルツハイマー病の診断と予後判定におけるマーカーとしてのｐ５３ペプチド

Also Published As

Publication number Publication date
CN104969071A (zh) 2015-10-07
US20150111220A1 (en) 2015-04-23
CA2893158A1 (en) 2014-06-05
US20150111223A1 (en) 2015-04-23
KR20150090240A (ko) 2015-08-05
WO2014085826A2 (en) 2014-06-05
EP2926138A4 (en) 2016-09-14
MX2015006757A (es) 2015-11-30
CN104969071B (zh) 2019-09-03
US20140234854A1 (en) 2014-08-21
BR112015012616A2 (pt) 2017-09-12
US20150111221A1 (en) 2015-04-23
EP2926138A2 (en) 2015-10-07
CN110596385A (zh) 2019-12-20
US20150111230A1 (en) 2015-04-23
SG11201504241QA (en) 2015-06-29
AU2013351947A1 (en) 2015-06-18
WO2014085826A3 (en) 2014-10-23
US20170285033A1 (en) 2017-10-05

Similar Documents

Publication Publication Date Title
CN104969071B (zh) 用于评估结肠肿瘤的存在或风险的方法
US11041866B2 (en) Pancreatic cancer biomarkers and uses thereof
JP6105491B2 (ja) 照合性細胞ベースのアッセイ及びその使用
EP3029153B1 (en) Mesothelioma biomarkers and uses thereof
US9689874B2 (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US20170176441A1 (en) Protein biomarker profiles for detecting colorectal tumors
WO2008064336A9 (en) Autoimmune disease biomarkers
HK1248316A1 (en) Methods of assessing colorectal health of an individual
WO2018068020A1 (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
US20240393337A1 (en) Lung Cancer Prediction and Uses Thereof
KR20240004546A (ko) 결장직장암에 대한 바이오마커
US20230048910A1 (en) Methods of Determining Impaired Glucose Tolerance

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161201

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161201

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170908

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171003

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180529